Treatment of Hepatic Failure with ex Vivo Pig-Liver Perfusion Followed by Liver Transplantation
Ravi S. Chari, Bradley H. Collins, John C. Magee, J. Michael DiMaio, Allan D. Kirk, Robert C. Harland, Richard L. McCann, Jeffrey L. Platt, and William C. Meyers
Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.
In 1990, more than 27,000 patients died of liver failure inthe United States1. Perfusion through a liver from another personor a member of another species, such as a monkey, outside thebody was used in the past to stabilize the condition of somepatients with acute or subacute liver failure2,3,4,5. Few patientssurvived, however, and this approach was superseded by orthotopicliver transplantation6. Liver transplantation is associatedwith higher mortality for patients with fulminant hepatic failurethan for patients with chronic liver disease, however. Patientswith fulminant hepatic failure often have multiorgan failureand hemodynamic . . . [Full Text of this Article]
Methods
Consent
Procurement of Pig Livers
Preparation of Patients and Perfusion Circuit
Stages of Hepatic Encephalopathy
Case Reports
Patient 1
Patient 2
Patient 3
Patient 4
Discussion
Source Information
From the Departments of Surgery (R.S.C., B.H.C., J.C.M., J.M.D., A.D.K., R.C.H., R.L.M., J.L.P., W.C.M.), Immunology (J.L.P.), and Pediatrics (J.L.P.), Duke University Medical Center and Durham Veterans Affairs Medical Center, Durham, N.C. Presented in part at the 19th Annual Scientific Meeting of the American Society of Transplant Surgeons, Houston, May 20-22, 1993.
Address reprint requests to Dr. Meyers at Box 3041, Duke University Medical Center, Durham, NC 27710.
References
This article has been cited by other articles:
Grosse-Siestrup, C., Pfeffer, J., Unger, V., Nagel, S., Witt, C., Fischer, A., Groneberg, D. A.
(2002). Isolated Hemoperfused Slaughterhouse Livers as a Valid Model to Study Hepatotoxicity. Toxicol Pathol
30: 749-754
[Abstract]
Lee, J.-H., Webb, G. C., Allen, R. D. M., Moran, C.
(2002). Characterizing and Mapping Porcine Endogenous Retroviruses in Westran Pigs. J. Virol.
76: 5548-5556
[Abstract][Full Text]
Groneberg, D. A., Grosse-Siestrup, C., Fischer, A.
(2002). In Vitro Models to Study Hepatotoxicity. Toxicol Pathol
30: 394-399
[Abstract]
Chapman, L. E., Bloom, E. T.
(2001). Clinical Xenotransplantation. JAMA
285: 2304-2306
[Full Text]
Qari, S. H., Magre, S., García-Lerma, J. G., Hussain, A. I., Takeuchi, Y., Patience, C., Weiss, R. A., Heneine, W.
(2001). Susceptibility of the Porcine Endogenous Retrovirus to Reverse Transcriptase and Protease Inhibitors. J. Virol.
75: 1048-1053
[Abstract][Full Text]
Adams, D. H., Chen, R. H., Kadner, A.
(2000). Cardiac xenotransplantation: clinical experience and future direction. Ann. Thorac. Surg.
70: 320-326
[Abstract][Full Text]
Czauderna, F., Fischer, N., Boller, K., Kurth, R., Tönjes, R. R.
(2000). Establishment and Characterization of Molecular Clones of Porcine Endogenous Retroviruses Replicating on Human Cells. J. Virol.
74: 4028-4038
[Abstract][Full Text]
Clark, M. A.
(1999). This Little Piggy Went to Market: The Xenotransplantation and Xenozoonose Debate. J Law Med Ethics
27: 137-152
Chapman, L. E., Folks, T. M., Salomon, D. R., Patterson, A. P., Eggerman, T. E., Noguchi, P. D.
(1995). Xenotransplantation and Xenogeneic Infections. NEJM
333: 1498-1501
[Full Text]
Cattral, M. S., Levy, G. A.
(1994). Artificial Liver Support -- Pipe Dream or Reality?. NEJM
331: 268-269
[Full Text]